Kelun-Biotech Partners with Windward Bio for Phase 2 Asthma Trial of SKB378/WIN378 Kelun-Biotech announces the initiation of a Phase 2 clinical trial for SKB378/WIN378, a novel treatment for asthma in partnership with Windward Bio.

Kelun-Biotech Partners with Windward Bio for Phase 2 Asthma Trial of SKB378/WIN378 #China #Chengdu #Kelun-Biotech #Windward_Bio #SKB378